Goldman Sachs Group Inc Deciphera Pharmaceuticals, Inc. Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.58 - $17.36 $4.68 Million - $5.98 Million	-344,634 Reduced 14.94%	1,962,841 $30.9 Million
Q4 2023 Feb 13, 2024	BUY	$10.11 - $16.54 $2.94 Million - $4.81 Million	290,968 Added 14.43%	2,307,475 $37.2 Million
Q3 2023 May 14, 2024	SELL	$12.46 - $15.48 $3.63 Million - $4.5 Million	-290,968 Reduced 12.61%	2,016,507 $25.6 Million
Q3 2023 Nov 14, 2023	SELL	$12.46 - $15.48 $1.34 Million - $1.66 Million	-107,527 Reduced 5.06%	2,016,507 $25.6 Million
Q2 2023 May 14, 2024	SELL	$13.28 - $15.96 $12.4 Million - $14.9 Million	-933,879 Reduced 30.54%	2,124,034 $29.9 Million
Q2 2023 Aug 14, 2023	SELL	$13.28 - $15.96 $12.4 Million - $14.9 Million	-933,879 Reduced 30.54%	2,124,034 $29.9 Million
Q1 2023 May 14, 2024	BUY	$14.26 - $22.1 $12.2 Million - $19 Million	857,540 Added 38.97%	3,057,913 $47.2 Million
Q1 2023 May 11, 2023	BUY	$14.26 - $22.1 $12.2 Million - $19 Million	857,540 Added 38.97%	3,057,913 $47.2 Million
Q4 2022 May 14, 2024	SELL	$14.85 - $19.04 $23.3 Million - $29.8 Million	-1,566,480 Reduced 41.59%	2,200,373 $36.1 Million
Q4 2022 Feb 13, 2023	SELL	$14.85 - $19.04 $23.3 Million - $29.8 Million	-1,566,480 Reduced 41.59%	2,200,373 $36.1 Million
Q3 2022 May 14, 2024	BUY	$12.38 - $20.23 $1.28 Million - $2.08 Million	103,034 Added 2.81%	3,766,853 $69.7 Million
Q3 2022 Nov 10, 2022	BUY	$12.38 - $20.23 $1.28 Million - $2.08 Million	103,034 Added 2.81%	3,766,853 $69.7 Million
Q2 2022 May 14, 2024	BUY	$9.11 - $13.98 $12.4 Million - $19 Million	1,356,344 Added 58.78%	3,663,819 $48.2 Million
Q2 2022 Aug 15, 2022	BUY	$9.11 - $13.98 $26.1 Million - $40 Million	2,861,642 Added 356.73%	3,663,819 $48.2 Million
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $19.5 Million - $31.5 Million	-2,833,333 Reduced 77.93%	802,177 $7.44 Million
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $24.7 Million - $119 Million	3,202,527 Added 739.64%	3,635,510 $35.5 Million
Q3 2021 Nov 10, 2021	BUY	$26.46 - $37.15 $11.5 Million - $16.1 Million	432,983 New	432,983 $14.7 Million

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account